Josh Welle

Doctor of Medicine,  CharitĂ© - Universitätsmedizin Berlin 

Location: Germany

Consulting Services

Biostatistics Journal Manuscript Legal Support Research Consulting Hospital-Pharmacy-Insurance

Areas Of Interest

Beverages, Sweetened Keratinocyte Growth Factor 2 Casein Kinase Igamma Shops, Hospital Prosolin Limb-Girdle Muscular Dystrophy, Type 2D Field, Hippocampus CA2 Dimeglumine, Gadolinium DTPA Herpestidae Defects, Color Vision Juice, Vegetable Warning, Black Box Filipendulas Premature Ventricular Complex Brucella ovis Symmetric Diabetic Proximal Motor Neuropathy Caprolactam Quorum Sensing Hepatitis B Virus Antibodies Legislation Cell Receptor, Pre-B Environmental Health Prairie Dogs Amiduret Trom L-myc Genes Renewal, Urban Animal Hospitals IkB DNA Binding Proteins Trihexosides, Ceramide

Professional Narrative

Dr. Josh Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Amgen 2011
Executive Director, Harvard Med 2019

Education

Master of Science in physician assistant, Perelman School of Medicine 2000
Master of Science in physician assistant, Harvard Medical School 2004

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :